P02 | THE C-C CHEMOKINE-RECEPTOR 2 (CCR2)/CCL2 AXIS PARTICIPATE IN PLATELET FUNCTION IN MYELOFIBROSIS
Myelofibrosis (MF) is the most severe myeloproliferative neoplasm driven by mutations of the MPL/JAK2 axis induced by megakaryocytes (MKs) with reduced GATA1 content1. The proinflammatory milieu in the bone marrow (BM) microenvironment favors the disease evolution, by sustaining BM fibrosis, hemato...
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
PAGEPress Publications
2025-08-01
|
| Series: | European Journal of Histochemistry |
| Subjects: | |
| Online Access: | https://www.ejh.it/ejh/article/view/4322 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chemokine CCL2 and its receptor CCR2 in different age groups of patients with COVID-19
by: Vahid Bagheri, et al.
Published: (2024-10-01) -
CCL2/C–C chemokine receptor type 2‐mediated interactions among mast cells, basophils, and endothelial cells
by: Maruša Rihar, et al.
Published: (2025-02-01) -
The CCL2-CCR2 axis drives neuromuscular denervation in amyotrophic lateral sclerosis
by: Bernát Nógrádi, et al.
Published: (2025-08-01) -
The role and therapeutic targeting of the CCL2/CCR2 signaling axis in inflammatory and fibrotic diseases
by: Shan Guo, et al.
Published: (2025-01-01) -
Regulatory effects of statins on CCL2/CCR2 axis in cardiovascular diseases: new insight into pleiotropic effects of statins
by: Hanieh Gholamalizadeh, et al.
Published: (2024-12-01)